1200 Pharma, the biotech company using medicinal chemistry technology and biomarker-driven assays to accelerate pre-clinical drug discovery and clinical approval timelines, has raised $5.5M in venture funding according to a recent SEC filing. The filing lists David Licata and Lee Sailor as executives and indicates that this round came from five investors. 1200 Pharma has now raised a total of $11.7M in reported equity funding.
The TechWatch Media Group audience is driving progress and innovation on a global scale. TechWatch Media is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a report like this. Find out more here.
